Breast Magnetic Resonance Imaging Can Predict Ki67 Discordance Between Core Needle Biopsy and Surgical Samples
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Breast Magnetic Resonance Imaging Can Predict Ki67 Discordance Between Core Needle Biopsy and Surgical Samples
Authors
Keywords
-
Journal
JOURNAL OF MAGNETIC RESONANCE IMAGING
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-06-01
DOI
10.1002/jmri.28231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as ground truth
- (2021) Philipp Mayer et al. CANCER IMAGING
- Evaluating Heterogeneity of Primary Lung Tumor Using Clinical Routine Magnetic Resonance Imaging and a Tumor Heterogeneity Index
- (2021) Nan Hu et al. Frontiers in Oncology
- Concomitant use of 18F-FDG PET-CT SUVmax is useful in the assessment of Ki67 labeling index in core-needle biopsy specimens of breast cancer
- (2021) Hiroki Nakajima et al. Gland Surgery
- Concordance of the molecular subtype classification between core needle biopsy and surgical specimen in primary breast cancer
- (2021) M. Pölcher et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Assessment of Apparent Diffusion Coefficients and SUVs as Predicators of Histological Differentiation in Anal Squamous Cell Carcinoma
- (2021) Arman Parsai et al. CLINICAL NUCLEAR MEDICINE
- Nomogram Based on Breast MRI and Clinicopathologic Features for Predicting Axillary Lymph Node Metastasis in Patients with Early-Stage Invasive Breast Cancer: A Retrospective Study
- (2021) Mei Xue et al. Clinical Breast Cancer
- Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer?
- (2020) Taiyo L. Harada et al. EUROPEAN RADIOLOGY
- Apparent Diffusion Coefficient to Evaluate Adult Intracranial Ependymomas: Relationship to Ki‐67 Proliferation Index
- (2020) Liu Xianwang et al. JOURNAL OF NEUROIMAGING
- Intratumoral heterogeneity of second-harmonic generation scattering from tumor collagen and its effects on metastatic risk prediction
- (2020) Danielle E. Desa et al. BMC CANCER
- Correlation of apparent diffusion coefficient values and peritumoral edema with pathologic biomarkers in patients with breast cancer
- (2020) Behnaz Moradi et al. CLINICAL IMAGING
- Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant
- (2019) Stephanie Robertson et al. BREAST CANCER RESEARCH AND TREATMENT
- Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk
- (2019) Jin You Kim et al. EUROPEAN RADIOLOGY
- Associations Between Apparent Diffusion Coefficient Values and the Prognostic Factors of Breast Cancer
- (2019) Bo Bae Choi JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
- Evaluation of Ki-67 Index in Core Needle Biopsies and Matched Breast Cancer Surgical Specimens
- (2018) Soomin Ahn et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Invasive Breast Cancer: Prognostic Value of Peritumoral Edema Identified at Preoperative MR Imaging
- (2018) Hyejin Cheon et al. RADIOLOGY
- Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting
- (2017) Teresa Gamucci et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Reliability of the Ki67-Labelling Index in Core Needle Biopsies of Luminal Breast Cancers is Unaffected by Biopsy Volume
- (2016) C. M. Focke et al. ANNALS OF SURGICAL ONCOLOGY
- Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers
- (2016) Hyung Sun Kim et al. PLoS One
- Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival
- (2016) Min Sun Bae et al. RADIOLOGY
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Breast MRI: EUSOBI recommendations for women’s information
- (2015) Ritse M. Mann et al. EUROPEAN RADIOLOGY
- Luminal-Type Breast Cancer: Correlation of Apparent Diffusion Coefficients with the Ki-67 Labeling Index
- (2015) Naoko Mori et al. RADIOLOGY
- Apparent diffusion coefficient as a potential surrogate marker for Ki-67 index in mucinous breast carcinoma
- (2014) Natsuko Onishi et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
- (2013) E. C. Inwald et al. BREAST CANCER RESEARCH AND TREATMENT
- Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters
- (2013) Naoko Mori et al. EUROPEAN RADIOLOGY
- Decline in Hand Bone Mineral Density Indicates Increased Risk of Erosive Change in Early Rheumatoid Arthritis
- (2013) R. J. Black et al. ARTHRITIS CARE & RESEARCH
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Sensitivity and Specificity of Unilateral Edema on T2w-TSE Sequences in MR-Mammography Considering 974 Histologically Verified Lesions
- (2010) Pascal A. T. Baltzer et al. Breast Journal
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started